Financials

Discussions Technicals Seasonals

6875 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMOSA BIOPHARM INC operating, investing, and financing activities

6875 free cash flow for Q2 24 is -108.72 M TWD. For 2023, 6875 free cash flow was -39.04 M TWD and operating cash flow was 42.42 M TWD.

Q3 '22

Q1 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q1 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—